BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16020129)

  • 21. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
    Lwaleed BA; Bass PS
    J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coxa magna quantification using MRI in Legg-Calve-Perthes disease.
    Sales de Gauzy J; Briot J; Swider P
    Clin Biomech (Bristol, Avon); 2009 Jan; 24(1):43-6. PubMed ID: 18992975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is conservative treatment really effective for Legg-Calvé-Perthes disease? A critical review of the literature.
    Sinigaglia R; Bundy A; Okoro T; Gigante C; Turra S
    Chir Narzadow Ruchu Ortop Pol; 2007; 72(6):439-43. PubMed ID: 18402012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of cheilectomy in Legg-Calve-Perthes disease: minimum 25-year follow-up of five patients.
    Rowe SM; Jung ST; Cheon SY; Choi J; Kang KD; Kim KH
    J Pediatr Orthop; 2006; 26(2):204-10. PubMed ID: 16557136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is intravascular coagulation the cause of Legg-Calve-Perthes disease?].
    Hvid I; Ingerslev J
    Ugeskr Laeger; 1999 May; 161(19):2819. PubMed ID: 10412324
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of plasma tissue factor and tissue factor pathway inhibitor levels in childhood hemangiomas.
    Türker M; Irken G; Oren H; Yilmaz S; Yüksel F; Olgun N
    Pediatr Blood Cancer; 2006 Dec; 47(7):914-7. PubMed ID: 16395682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a better understanding of the aetiology of Legg-Calvé-Perthes' disease: acetabular retroversion may cause abnormal loading of dorsal femoral head-neck junction with restricted blood supply to the femoral epiphysis.
    Eijer H
    Med Hypotheses; 2007; 68(5):995-7. PubMed ID: 17118567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of eNOS 27-bp VNTR, 894G>T and 786T>C polymorphisms with susceptibility to Legg-Calve-Perthes Disease in Iranian children.
    Azarpira MR; Ghilian MM; Sobhan MR; Mahdinezhad-Yazdi M; Aghili K; Ahrar H; Neamatzadeh H
    J Orthop; 2019; 16(2):137-140. PubMed ID: 30890857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The Legg-Calvé-Perthes disease: which assessment? Which therapeutic approach?].
    Ceroni D; Kaelin A
    Rev Med Suisse; 2006 Dec; 2(92):2908-12. PubMed ID: 17233495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Children with Legg-Perthes diseases.
    Pokharel RK; Matsuo M; Shiba R; Fujii S
    Clin Orthop Relat Res; 1999 Jun; (363):268-9. PubMed ID: 10379332
    [No Abstract]   [Full Text] [Related]  

  • 32. Is there functional vascular information in anatomical MR sequences? A preliminary in vivo study.
    Winzenrieth R; Claude I; Hobatho MC; Sebag G
    IEEE Trans Biomed Eng; 2006 Jun; 53(6):1190-5. PubMed ID: 16761847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
    Lean SY; Ellery P; Ivey L; Thom J; Oostryck R; Leahy M; Baker R; Adams M
    Haematologica; 2006 Oct; 91(10):1360-6. PubMed ID: 17018385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulated SOX9 mediated by miR-206 promoted cell apoptosis in Legg-Calvé-Perthes disease.
    Luo J; Han J; Li Y; Liu Y
    Oncol Lett; 2018 Jan; 15(1):1319-1324. PubMed ID: 29387248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Children with acute Perthes' disease have asymmetrical lower leg growth and abnormal collagen turnover.
    Crofton PM; Macfarlane C; Wardhaugh B; Ranke MB; Elmlinger MW; Kelnar CJ; Macnicol MF
    Acta Orthop; 2005 Dec; 76(6):841-7. PubMed ID: 16470439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hip deformity in symptomatic adult Perthes' disease.
    Eijer H; Berg RP; Haverkamp D; Pécasse GA
    Acta Orthop Belg; 2006 Dec; 72(6):683-92. PubMed ID: 17260605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.
    Dahm A; Rosendaal FR; Andersen TO; Sandset PM
    Br J Haematol; 2006 Feb; 132(3):333-8. PubMed ID: 16409298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperactivity and the psychological burden of Perthes disease: a case-control study.
    Perry DC; Pope D; Bruce CE; Dangerfield P; Hall AJ; Platt MJ
    J Pediatr Orthop; 2013 Sep; 33(6):644-9. PubMed ID: 23812131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Perthes disease].
    Krauspe R; Raab P
    Orthopade; 1997 Mar; 26(3):289-302. PubMed ID: 9198804
    [No Abstract]   [Full Text] [Related]  

  • 40. Legg-Calvé-Perthes disease: one century later.
    Moens P; Fabry G
    Acta Orthop Belg; 2003 Apr; 69(2):97-103. PubMed ID: 12769008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.